This product is no longer in stock
Warning: Last items in stock!
Use and effective range:
Applications: Estrogen receptor blocker, post-cycle therapy, against gynecomastia
Anabolic components: not exist
Androgenic components: not exist
Dose range and duration of use:
Beginners: 10-40mg / day
Hobby: 10-40mg / day
Professional range: 20-80mg / day
Women: 10-40mg / day
Application period: 2-16 weeks
Active-Life: Less than 24 hours
Drug Class: Estrogen-Agonist/-Antagonist (Oral)
Average Reported Dosage: 10-80-mg daily
Water Retention: No
High Blood Pressure: Rare (not normally attributed to the drug itself)
Liver Toxic: Yes
Tamoxifen Citrate is a drug commonly referred to as an anti-estrogen. This would suggest less or no estrogen is produced due to the drug’s actions as in the case of Teslac. Actually, Tamoxifen Citrate is an estrogen antagonist, meaning it competes with estrogen at estrogen receptor- sites. This prevents the active estrogen from entering its receptor and creating an estrogenic complex capable of activity. Since many AAS aromatize (covert to estrogen) to some degree, the control of feminizing side effects (males should pay attention here) is important. Males normally have a very low estrogen level.
During AAS cycles, due to aromatization, estrogen levels rise considerably. This elevated estrogen level can cause feminizing side effects such as increased fat deposits, water retention, and gynecomastia (growth of breast gland tissue and painful tumors under the nipple). As a rule, it is more the ratio of androgens-to-estrogens than the simple increase in estrogen that actually initiates feminizing side effects.